BridgeBio Oncology Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2026 | 17.88 M | $136.23 M | 0.00% | 22,333.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2026 | 4.89 M | $37.23 M | 0.00% | 6,102.69% |
| OMEGA FUND MANAGEMENT, LLC | 08/14/2026 | 3.29 M | $25.07 M | 0.00% | 4,109.30% |
| ECOR1 CAPITAL, LLC | 08/14/2026 | 2.82 M | $21.51 M | 0.00% | 3,526.53% |
| ALPHABET INC. | 08/07/2026 | 2.82 M | $21.51 M | 0.00% | 3,526.53% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 2.79 M | $21.25 M | -1.03% | 3,484.28% |
| CITADEL ADVISORS LLC | 09/02/2026 | 2.62 M | $19.95 M | 3.52% | 3,270.08% |
| STATE STREET CORP | 09/22/2026 | 1.04 M | $7.90 M | 358.10% | 1,294.84% |
| BLACKROCK, INC. | 08/07/2026 | 2.15 M | $16.41 M | 3.15% | 2,690.73% |
| LAURION CAPITAL MANAGEMENT LP | 08/13/2026 | 2.00 M | $15.26 M | 4.16% | 2,501.69% |
| AISLING CAPITAL MANAGEMENT LP | 08/13/2026 | 1.02 M | $7.76 M | 0.00% | 1,271.66% |
| NOVO HOLDINGS A/S | 08/14/2026 | 2.25 M | $17.15 M | 2.93% | 2,810.60% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 1.76 M | $13.44 M | 32.83% | 2,203.51% |
| ENAVATE SCIENCES GP, LLC | 08/14/2026 | 2.63 M | $20.02 M | 0.00% | 3,281.47% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.01 M | $15.28 M | 272.49% | 2,505.37% |
| OPALEYE MANAGEMENT INC. | 08/14/2026 | 700.00 K | $5.33 M | 1,213.76% | 874.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 622.35 K | $4.74 M | 7.44% | 777.41% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 558.53 K | $4.26 M | 141.74% | 697.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 460.99 K | $3.51 M | 100.00% | 575.84% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 400.00 K | $3.05 M | 0.00% | 499.66% |
| ROYCE & ASSOCIATES LP | 08/14/2026 | 384.94 K | $2.93 M | -39.52% | 480.85% |
| CATALIO CAPITAL MANAGEMENT, LP | 08/14/2026 | 318.41 K | $2.43 M | 100.00% | 397.74% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 300.00 K | $2.29 M | -31.49% | 374.75% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 291.52 K | $2.22 M | 14.62% | 364.16% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 286.52 K | $2.18 M | -1.47% | 357.91% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 286.52 K | $2.18 M | 100.00% | 357.91% |
| CASDIN CAPITAL, LLC | 08/14/2026 | 282.31 K | $2.15 M | 0.00% | 352.65% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 273.53 K | $2.08 M | -14.75% | 341.68% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 08/13/2026 | 244.44 K | $1.87 M | -1.89% | 305.35% |
| FMR LLC | 08/13/2026 | 240.59 K | $1.83 M | 0.12% | 300.53% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 191.15 K | $1.46 M | 110.48% | 238.78% |
| NORTHERN TRUST CORP | 08/13/2026 | 186.48 K | $1.42 M | 82.36% | 232.95% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2026 | 130.63 K | $995.39 K | 0.00% | 163.17% |
| UBS GROUP AG | 08/13/2026 | 114.66 K | $873.67 K | 127.26% | 143.22% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 105.48 K | $803.76 K | -60.34% | 131.76% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 102.09 K | $777.89 K | -39.08% | 127.52% |
| MOORE CAPITAL MANAGEMENT, LP | 08/14/2026 | 100.00 K | $762.00 K | 0.00% | 124.92% |
| TOROSO INVESTMENTS, LLC | 08/13/2026 | 93.34 K | $711.24 K | 13.59% | 116.60% |
| TEMA ETFS LLC | 07/10/2026 | 93.34 K | $711.24 K | 13.59% | 116.60% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 08/14/2026 | 88.90 K | $690.71 K | 523.91% | 111.04% |
| PALUMBO WEALTH MANAGEMENT LLC | 08/12/2026 | 85.62 K | $652.46 K | 100.00% | 106.96% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 77.14 K | $587.81 K | 100.00% | 96.36% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 62.00 K | $472.44 K | 100.00% | 77.45% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 58.60 K | $446.53 K | -42.49% | 73.20% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 43.85 K | $334.16 K | 0.00% | 54.78% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 42.73 K | $325.60 K | -25.78% | 53.38% |
| VIRTUS INVESTMENT ADVISERS, INC. | 08/11/2026 | 42.22 K | $321.72 K | 100.00% | 52.74% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 09/09/2026 | 27.98 K | $213.24 K | -21.60% | 34.96% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 26.49 K | $201.82 K | 100.00% | 33.08% |
| RAFFERTY ASSET MANAGEMENT, LLC | 08/14/2026 | 22.61 K | $172.26 K | 100.00% | 28.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BridgeBio Oncology Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 87 institutional investors and hedge funds held shares of BridgeBio Oncology Therapeutics Inc.. The most heavily invested institutionals were:
Cormorant Asset Management, LP: 17.88 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 4.89 M
Omega Fund Management, LLC: 3.29 M
Alphabet Inc.: 2.82 M
EcoR1 Capital, LLC: 2.82 M
WELLINGTON MANAGEMENT GROUP LLP: 2.79 M
74,219.11% of BridgeBio Oncology Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 60.21 M shares in the last 24 months. This purchase volume represents approximately $620.78 M in transactions.